BLAU (BLAU3) Main Indicators
Basic Data - BLAU3
| Company | BLAU |
| Corporate Name | BLAU FARMACÊUTICA S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | A Companhia dedica-se à fabricação. comercialização. pesquisa e desenvolvimento de medicamentos de alta complexidade. |
| Share | BLAU3 |
| Quote Date | 04/02/2025 |
| Share Type | ON |
| Last Closing | R$ 12.91 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 8.32 M |
| Last Statement | DFP - 12/31/2024 |
| Sector | Saúde |
| Subsector | Comércio e Distribuição |
| Segment | Medicamentos e Outros Produtos |
| Participation Indexes | IBRA, ICON, IGC, IGCT, IGNM, ITAG, SMLL |
| Updated 04/03/2025 | |
Relative Prices - BLAU3
| Price/Earnings | 10.66 |
| Price/SBV | 1.07 |
| Price/Net Sales | 1.32 |
| Price/CFO | 4.57 |
| Price/FCF | 6.35 |
| Price/Total Assets | 0.68 |
| Price/EBIT | 7.04 |
| Price/Working Capital | 2.03 |
| Price/NCAV | -21.14 |
| EV/EBIT | 8.64 |
| EV/EBITDA | 7.47 |
| EV/Net Sales | 1.62 |
| EV/CFO | 5.60 |
| EV/FCF | 7.80 |
| EV/Total Assets | 0.83 |
| Company Market Cap | R$ 2.32 B |
| Enterprise Value | R$ 2.84 B |
| Current Financial Statement Date | 12/31/2024 |
| Current Share Price | R$ 12.91 |
| Share Price Date | 04/02/2025 |
| Dividend Yield | 3.81% |
| Updated 04/03/2025 | |
Income Statement - BLAU3
| Net Revenue | R$ 1.75 B |
| Gross Result | R$ 658.75 M |
| EBIT | R$ 328.80 M |
| Depreciation and Amortization | - R$ 51.76 M |
| EBITDA | R$ 380.56 M |
| Net Profit | R$ 217.21 M |
| Net Profit/Share | R$ 1.21 |
| Updated 03/18/2025 | |
| Net Revenue | R$ 456.03 M |
| Gross Result | R$ 182.32 M |
| EBIT | R$ 102.43 M |
| Depreciation and Amortization | - R$ 14.40 M |
| EBITDA | R$ 116.83 M |
| Net Profit | R$ 57.84 M |
| Profit/Share | R$ 0.32 |
| Updated 03/18/2025 | |
Price and Volume Behavior - BLAU3
| Lowest Price 52 weeks | R$ 9.04 |
| Highest Price 52 weeks | R$ 16.68 |
| Variation 2025 | 2.34% |
| Variation 1 year | 10.05% |
| Variation 2 years(total) | -42.88% |
| Variation 2 years(yearly) | -24.34% |
| Variation 3 years(total) | -51.06% |
| Variation 3 years(yearly) | -21.16% |
| Variation 4 years(total) | - |
| Variation 4 years(yearly) | - |
| Variation 5 years(total) | - |
| Variation 5 years(yearly) | - |
| Average Daily Volume (3 months) | R$ 2.82 M |
| Updated 04/03/2025 | |
Returns and Margins - BLAU3
| Return on Initial Tangible Capital | 9.02% |
| Return on Initial Invested Capital | 8.42% |
| Pre-Tax Return on Initial Tangible Capital | 13.66% |
| Pre-Tax Return on Initial Invested Capital | 12.75% |
| Return on Initial Shareholder´s Equity | 10.85% |
| Return on Initial Asset | 7.11% |
| Gross Margin | 37.55% |
| Net Margin | 12.38% |
| EBIT Margin | 18.74% |
| EBITDA Margin | 21.69% |
| Initial Asset Turnover | 0.57 |
| Financial Leverage | 1.58 |
| Liabilities/Net Worth | 0.58 |
| Net Debt/EBITDA | 1.38 |
| Updated 03/18/2025 | |
Balance Sheet - BLAU3
| Cash and Cash Equivalents | R$ 33.32 M |
| Total Assets | R$ 3.41 B |
| Short-Term Debt | R$ 73.36 M |
| Long-Term Debt | R$ 485.59 M |
| Gross Debt | R$ 558.95 M |
| Net Debt | R$ 525.64 M |
| Shareholder´s Equity | R$ 2.16 B |
| Share Book Value | R$ 12.06 |
| Common Shares | 179,393,939 |
| Preferred Shares | 0 |
| Total | 179,393,939 |
| Common Shares in Treasury | 1,713,200 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 1,713,200 |
| Common Shares (Except Treasury) | 177,680,739 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 177,680,739 |
| Updated 03/18/2025 | |
Cash Flow - BLAU3
| Operating Cash Flow | R$ 507.20 M |
| Cash Flow from Investments | - R$ 314.72 M |
| Financing Cash Flow | - R$ 190.67 M |
| Increase (Reduction) in Cash and Equivalents | R$ 1.82 M |
| Updated 03/18/2025 | |
| Operating Cash Flow | R$ 172.53 M |
| Cash Flow from Investments | - R$ 131.10 M |
| Financing Cash Flow | - R$ 28.81 M |
| Increase (Reduction) in Cash and Equivalents | R$ 12.61 M |
| Updated 03/18/2025 | |
Experimental - BLAU3
| CAPEX 3 months | - R$ 54.77 M |
| Free Cash Flow 3 months | R$ 117.76 M |
| CAPEX 12 months | - R$ 142.67 M |
| Free Cash Flow 12 months | R$ 364.53 M |
| Updated 03/18/2025 | |